<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4B8E83F1-1755-4FA2-8767-31A3E9591295"><gtr:id>4B8E83F1-1755-4FA2-8767-31A3E9591295</gtr:id><gtr:name>Laboratory of the Government Chemist (LGC) Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8B42480C-C16B-45BD-A61E-FCB97FD77B2C"><gtr:id>8B42480C-C16B-45BD-A61E-FCB97FD77B2C</gtr:id><gtr:name>RIKEN</gtr:name><gtr:address><gtr:line1>1-7-22, Suehiro-cho</gtr:line1><gtr:line2>Tsurumi-ku</gtr:line2><gtr:line4>Yokohama</gtr:line4><gtr:line5>Kanagawa 230-0045</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF0A0061-F60F-4692-947B-E406296939F5"><gtr:id>EF0A0061-F60F-4692-947B-E406296939F5</gtr:id><gtr:name>Chinese Academy of Sciences</gtr:name><gtr:address><gtr:line1>52 Sanlihe Road</gtr:line1><gtr:postCode>100864</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4B8E83F1-1755-4FA2-8767-31A3E9591295"><gtr:id>4B8E83F1-1755-4FA2-8767-31A3E9591295</gtr:id><gtr:name>Laboratory of the Government Chemist (LGC) Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8B42480C-C16B-45BD-A61E-FCB97FD77B2C"><gtr:id>8B42480C-C16B-45BD-A61E-FCB97FD77B2C</gtr:id><gtr:name>RIKEN</gtr:name><gtr:address><gtr:line1>1-7-22, Suehiro-cho</gtr:line1><gtr:line2>Tsurumi-ku</gtr:line2><gtr:line4>Yokohama</gtr:line4><gtr:line5>Kanagawa 230-0045</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF0A0061-F60F-4692-947B-E406296939F5"><gtr:id>EF0A0061-F60F-4692-947B-E406296939F5</gtr:id><gtr:name>Chinese Academy of Sciences</gtr:name><gtr:address><gtr:line1>52 Sanlihe Road</gtr:line1><gtr:postCode>100864</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4FAF4B56-3F0D-482B-B7E9-A3D648C891AD"><gtr:id>4FAF4B56-3F0D-482B-B7E9-A3D648C891AD</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:surname>Taylor</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_U127597124"><gtr:id>5E0ECF97-ADA5-4951-875A-4DDC76B42F91</gtr:id><gtr:title>Using signatures of mutation and selection in genome evolution to interpret contemporary genetic variation</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_U127597124</gtr:grantReference><gtr:abstractText>Improving our understanding of genetic differences between species allows us to better interpret genetic risk in people. We are all at risk of developing a wide range of diseases, some very common, including heart disease, diabetes, dementia and cancer. But such risks differ hugely between individuals, and are to a large degree influenced by the sequence of DNA in our cells. 

The big question is which of the many thousands of DNA differences between individuals are responsible for increasing or decreasing their risk of developing a given disease. The historic record of evolution can provide some answers. We can read it as the differences in DNA between species, for example human versus mouse. The pattern of differences between species can reveal functionally important regions of DNA. Contrasting the between species pattern with the differences between people can point to the critically important changes that influence disease risk. 

More broadly, we compare how DNA has changed between species with the differences observed between people. This allows us to study why and where DNA changes (mutations) arise, and what the functional consequences of those changes are. We are applying these methods to understand the genetic basis of many rare and common diseases.</gtr:abstractText><gtr:technicalSummary>We are endeavouring to understand the processes of selection and mutation that are acting to shape genomes. It is well known that selection shapes the pattern of genomic changes that accumulate as populations diverge from a common ancestor. This has proven to be a very useful signature for the identification of functionally important regions of the genome. But it is becoming increasingly clear that fluctuations in the pattern of new mutations can also generate superficially similar signals. Improved separation of these confounding evolutionary signatures is crucial if we are to understand how organisms evolve, and to relate contemporary genetic changes to human biology and disease. 

The results of this research fall into three broad categories: (1) An improved understanding of mutational mechanisms - why and where particular types of mutation occur. This is of particular importance in understanding the progression of cancers and explaining why some genes appear to carry a higher detrimental mutational load in the population than others. (2) Better detection of both purifying and diversifying selection for the interpretation of function and relating functional genomic measures of the genome (e.g. chromatin, origins of replication, regulatory sequences) to evolution. (3) The development and application of methods to identify genes, pathways and biological systems enriched for deleterious mutations associated with human genetic diseases and cancer. These approaches build on established techniques from the field of evolutionary biology and can be applied to all genetic diseases.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1944551</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>RIKEN</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>Omics Science Center</gtr:department><gtr:description>FANTOM5 Consortium</gtr:description><gtr:id>4C0DA392-2F60-4C1B-A384-E1505C66FF72</gtr:id><gtr:impact>The FANTOM5 Consortium is a a multi-national, multi-disciplinary project to investigate transcriptional regulation across mammalian genomes. The project traverses the fields of genomics, immunology, neuroscience, computational and mathematical biology.</gtr:impact><gtr:outcomeId>iPdFstvtLTh-1</gtr:outcomeId><gtr:partnerContribution>Provision of exceptional primary data on which research is based.</gtr:partnerContribution><gtr:piContribution>We are leading the evolutionary based analysis of this data. Comparing the patterns of transcriptional regulation between species to understand how the regulatory networks have evolved. We are also contributing to the primary filtering, quality control and interpretation of the data.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>RIKEN</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>Institute of Physical and Chemical Research (RIKEN)</gtr:department><gtr:description>FANTOM6 Consortium</gtr:description><gtr:id>99F015A2-0F3C-4852-B0F3-114AEE5B746B</gtr:id><gtr:impact>Project is ongoing - no impact yet.</gtr:impact><gtr:outcomeId>56d85e8ec590b9.88080416-1</gtr:outcomeId><gtr:partnerContribution>Planning, coordination and primary data generation.</gtr:partnerContribution><gtr:piContribution>Planning of large scale systematic study on lncRNA and their effect on gene regulation. Planning and initiating analysis of the resulting data.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chinese Academy of Sciences</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:department>CAS-MPG Partner Institute for Computational Biology (PICB)</gtr:department><gtr:description>mir-941</gtr:description><gtr:id>F7575D66-0F42-4005-AB30-E5BA313F62D3</gtr:id><gtr:impact>Manuscript published PMID: 23093182. Agreement to seek joint funding to support further studies.

Public engagement of science - this group took the lead in communicating the results and insights of this work to the general public: press release, radio interviews and articles in the poplar media (e.g. The Times, The Independent and news agencies across the world). See public engagement section.</gtr:impact><gtr:outcomeId>jfGPChtFWfd-1</gtr:outcomeId><gtr:partnerContribution>Generation of molecular biological data, genetic data analysis.</gtr:partnerContribution><gtr:piContribution>Data analysis, in-particular to show how the miR-941 locus evolved through the primate lineage from an evolutionarily volatile tandemly repetitive sequence. Writing and editing of the manuscript, preparation of figures.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Laboratory of the Government Chemist (LGC) Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Accurate measurement of nucleic acids</gtr:description><gtr:id>B9C51B30-BAF1-419C-A0D8-8D8C6E87D316</gtr:id><gtr:impact>PMID:22841564
PMID:25539843</gtr:impact><gtr:outcomeId>X74ijAhCdPj-1</gtr:outcomeId><gtr:partnerContribution>Preparation and generation of known reference data.</gtr:partnerContribution><gtr:piContribution>Development of novel methods to explore the quantisation of DNA methylation.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Edinburgh International Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0B7FD6C5-F7E2-4AE4-A89D-3B483F88C315</gtr:id><gtr:impact>One on one interaction with over 100 children and their families. Demonstration, answering questions and provoking thought. Two doctoral candidate students participated in this activity.

Enthusiastic participation from children and parents. Answering more in-depth questions on genetics from the general public.</gtr:impact><gtr:outcomeId>WKYZmADFruN</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit and presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>72EC1D07-84AB-4461-BCB8-46F46B84D020</gtr:id><gtr:impact>Presentation to 14-15 year olds, whole year group. Description of genomic medicine and discussion of whole genome sequencing.</gtr:impact><gtr:outcomeId>58be9068a95d83.48298004</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A-IMBN of mice and men</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C0B69FE3-FD76-4C83-9BA6-57EC60BA16C5</gtr:id><gtr:impact>Assistance drafting a broad audience highlight of our recently published work. Wide audience in the Asia-Pacific biomedical research community.

Positive feedback from Australian and Japanese researchers.</gtr:impact><gtr:outcomeId>Mmvy5oVZyaS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (Edinburgh Nov 2012)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3643B793-3D1D-43A3-A848-161468B54896</gtr:id><gtr:impact>Presentations given to three groups of apx. 30 children (90 children in total). Each presentation lasted 40 minutes and included formal presentation, guided discussions and hands-on practical. Children were 8 to 9 years old.

Pupils very enthusiastic, parents commenting on positive reception. Invitation to return to school and make a regular annual contribution.</gtr:impact><gtr:outcomeId>fGEc4S1jr7s</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Director Genetics Society studentship programme</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1ABEAF14-3EBB-431C-B9BC-990E3019C260</gtr:id><gtr:impact>Coordination of summer projects for 34 undergraduate students in labs across UK (international participants). Running residential summer school for participants including media engagement.</gtr:impact><gtr:outcomeId>56d867d363b0a7.93536055</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.genetics.org.uk/Funding/GeneticsSocietySummerStudentships.aspx</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release and subsequent article in The Times</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8D497C37-C3A2-41D6-A314-D01C7766299C</gtr:id><gtr:impact>Coordination of international press release regarding the FANTOM5 Nature publication. Interviewed by The Times and story picked up by many media outlets.

Asked about the relevant research at the school gate.</gtr:impact><gtr:outcomeId>542f051270eba6.27411013</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>miR-941 Radio interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8A7A505F-3B8A-41F4-97C2-C73720DBF381</gtr:id><gtr:impact>Interview for BBC radio describing the results of the miR-941 story.

Further interest from other media outlets.</gtr:impact><gtr:outcomeId>VDvR1f1V48k</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genetics Society board election</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>450C843F-7AA6-4E54-9962-8337BC2986F0</gtr:id><gtr:impact>Elected as voting member to the executive board of the Genetics Society. Presiding over grant applications, academic meetings.

Grants reviewed, awarded. Decisions made on support for meetings. Public engagement strategy discussions.</gtr:impact><gtr:outcomeId>SrD4TV4SkvJ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.genetics.org.uk/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Strategic planning for national development in high throughput sequencing</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B08D801D-8F08-4B20-9A7B-A7D0FB079B57</gtr:id><gtr:impact>Asked to provide technical and strategic insight into current and future high throughput sequencing technology. Influenced decision making on future investments and infrastructure planning.

Confidential.</gtr:impact><gtr:outcomeId>542f05dd333924.98762376</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>miR-941 Press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9216D07A-D5BE-4137-8DCB-27F811448D68</gtr:id><gtr:impact>Press release describing the miR-941 story &amp;quot;New brain gene born&amp;quot;.

Considerable press coverage with at least 33 resulting articles (as counted by Google News) both within the UK and internationally (US, Australia, China, Japan, Russia, Germany), invitations to interview on BBC radio.</gtr:impact><gtr:outcomeId>QkBwvnXNYnT</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lab Times profile of group research</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8ACF5320-F433-43EB-80EC-CCC181EA8159</gtr:id><gtr:impact>Research and approaches of the lab was profiled in extensive article published in Lab Times.</gtr:impact><gtr:outcomeId>56d868f1a1e4c1.52082381</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.labtimes-archiv.de/epaper/LT_15_03/index.html#31</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>miR-941 Times article</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1DB41D98-5A10-4F7D-AF8B-8EA1D66BD73B</gtr:id><gtr:impact>A prominent almost full-page article in The Times describing our recent work on miR-941. Extensive interaction with the correspondent to ensure the correct message and technical accuracy of the article. http://www.thetimes.co.uk/tto/science/biology/article3600723.ece

Positive feedback from both colleagues and members of the public. Further questions from members of the public wanting to dig deeper into the story. Follow-up stories in many online and print publications across the world.</gtr:impact><gtr:outcomeId>jgpGfxDuTkq</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Capital Equipment</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>ED880B68-C35A-4D13-9929-BC155689BE61</gtr:id><gtr:outcomeId>56d86226c309e0.76088982</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Scottish Genomes Partnership</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0DD577E4-7E19-482D-9B48-FFE70B59B33E</gtr:id><gtr:outcomeId>56d8631be4a833.43836386</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>67000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Medical Research Foundation</gtr:department><gtr:description>Equipment funds</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>C0440</gtr:fundingRef><gtr:id>7478F653-A1D9-427C-A5A2-D104351898C0</gtr:id><gtr:outcomeId>kqAXnRVWyCM</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>233584</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ECAT Fellowship for Thomas Williams</gtr:description><gtr:end>2019-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>3C85D21E-E606-4DD7-A593-40E649DF0397</gtr:id><gtr:outcomeId>58bea549622344.38548068</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A method to detect ribonucleotides embedded in DNA, a potential mutagenic lesion and also a means to track the enzymology of DNA replication.</gtr:description><gtr:id>FEDE2F3C-65FC-49CA-9D3E-293C1D830012</gtr:id><gtr:impact>Multiple review articles covering technology, substantial twitter activity and rapidly and highly cited work (30 citations in first 12 months of publication). Popular scientific media reported on the work including Technobahn, Phys.org, Slash.dot, BioPortfolio, GenomeWeb, EurekAlert, NanoWerk and ScienceNewsline.</gtr:impact><gtr:outcomeId>56d877db4b0765.50065190</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EmRiboSeq</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>Released under Artistic License 2.0

SuRFR prioritises variants in order of most likely to be functional to least on a combination of
genomic annotations including conservation, chromatin states, minor allele frequency and DNase
hypersensitivity. By combining data from multiple publicly available sources, this package can rank SNPs based
on the likelihood of functionality. This method is particularly good at prioritising functional noncoding
SNPs over a background set.We have designed this method as an aid to identifying disease
causing and/or disease-associated SNPs for genomics projects such as next generation sequencing
projects and genome wide association studies.</gtr:description><gtr:id>17E71808-5840-4979-9C04-614BCDC60D53</gtr:id><gtr:impact>Use by multiple research groups to prioritise the investigation of candidate functional variants in positionally implicated regions of the genome.</gtr:impact><gtr:outcomeId>56d892dd0c3f31.45840307</gtr:outcomeId><gtr:title>SuRFR</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.cgem.ed.ac.uk/resources/SuRFR/</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6496D756-9C77-4920-B49E-3D052D91AFB9</gtr:id><gtr:title>Mutational Biases Drive Elevated Rates of Substitution at Regulatory Sites across Cancer Types.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb316f02bf928cae671c4e7fff09f704"><gtr:id>cb316f02bf928cae671c4e7fff09f704</gtr:id><gtr:otherNames>Kaiser VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>582c32dcc540a4.94169214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83095384-B2A4-4F99-AF8F-56886EBF21F1</gtr:id><gtr:title>Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3d22e2355b3c9cadbbdf617801ed83f"><gtr:id>f3d22e2355b3c9cadbbdf617801ed83f</gtr:id><gtr:otherNames>Reijns MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>pm_12555_25_22579044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD1AB8FA-4C0B-46D9-AA5E-DDFBCA0C806D</gtr:id><gtr:title>Monoallelic and biallelic mutations in MAB21L2 cause a spectrum of major eye malformations.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20eee06f2065edac7c2a2235ff25b9b7"><gtr:id>20eee06f2065edac7c2a2235ff25b9b7</gtr:id><gtr:otherNames>Rainger J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>542f020a143744.69170241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B109887E-BF3E-44DB-85CE-91A64AA853F2</gtr:id><gtr:title>Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1cdd2b7d864d5d0390a254387307ae2"><gtr:id>b1cdd2b7d864d5d0390a254387307ae2</gtr:id><gtr:otherNames>Schroder K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12555_25_22451944</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03DAA2A6-87E8-4BCF-986C-65176D357879</gtr:id><gtr:title>Functional analysis of a novel ENU-induced PHD finger 11 (Phf11) mouse mutant.</gtr:title><gtr:parentPublicationTitle>Mammalian genome : official journal of the International Mammalian Genome Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0938-8990</gtr:issn><gtr:outcomeId>542f02096503b1.20471385</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8A3E595-8C36-4DA2-A033-4682B611996B</gtr:id><gtr:title>A CGG-repeat expansion mutation in ZNF713 causes FRA7A: association with autistic spectrum disorder in two families.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ac4daf46fe50c1941d54df99d9622dd"><gtr:id>2ac4daf46fe50c1941d54df99d9622dd</gtr:id><gtr:otherNames>Metsu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>542f020ab25a29.14582675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5F1279E-A94E-4840-8AB0-EA439C727B6A</gtr:id><gtr:title>Application of next generation qPCR and sequencing platforms to mRNA biomarker analysis.</gtr:title><gtr:parentPublicationTitle>Methods (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/634ffa1fb6f9ad07ec2283dfdd8a9d02"><gtr:id>634ffa1fb6f9ad07ec2283dfdd8a9d02</gtr:id><gtr:otherNames>Devonshire AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1046-2023</gtr:issn><gtr:outcomeId>pm_12555_25_22841564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8CEB2DF-372D-404B-8621-74CE438399DA</gtr:id><gtr:title>Heterozygous loss-of-function mutations in YAP1 cause both isolated and syndromic optic fissure closure defects.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8b057f36c63e21093af1f9fe1543281"><gtr:id>e8b057f36c63e21093af1f9fe1543281</gtr:id><gtr:otherNames>Williamson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>542f020a830988.09291903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16595C2D-5591-4F5D-B735-5AF992128B0E</gtr:id><gtr:title>Enhancer Turnover Is Associated with a Divergent Transcriptional Response to Glucocorticoid in Mouse and Human Macrophages.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f76bdee3697d9b0b441c9e4b5dcb93a"><gtr:id>3f76bdee3697d9b0b441c9e4b5dcb93a</gtr:id><gtr:otherNames>Jubb AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56d890334e62d0.63479547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E2E5B81-C859-47CB-8AA1-5F646B05C6EB</gtr:id><gtr:title>Evolution of the human-specific microRNA miR-941.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/674c174787c6c4191fafa56c3cf7b06c"><gtr:id>674c174787c6c4191fafa56c3cf7b06c</gtr:id><gtr:otherNames>Hu HY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_12555_25_23093182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00EB6EF0-49D6-406A-BE1D-9FB107C2A907</gtr:id><gtr:title>Lagging-strand replication shapes the mutational landscape of the genome.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/889e7d70aa07dbaa35dc56190482afcf"><gtr:id>889e7d70aa07dbaa35dc56190482afcf</gtr:id><gtr:otherNames>Reijns MAM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5675df0948cad</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D085745-5396-4482-A8B9-29A318BD09B2</gtr:id><gtr:title>Homozygous loss-of-function variants in European cosmopolitan and isolate populations.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb316f02bf928cae671c4e7fff09f704"><gtr:id>cb316f02bf928cae671c4e7fff09f704</gtr:id><gtr:otherNames>Kaiser VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>569524374df9c9.18312135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86C0792C-1EF2-4904-981B-C20E1B48401E</gtr:id><gtr:title>FRA2A is a CGG repeat expansion associated with silencing of AFF3.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ac4daf46fe50c1941d54df99d9622dd"><gtr:id>2ac4daf46fe50c1941d54df99d9622dd</gtr:id><gtr:otherNames>Metsu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>542f020a50f5e0.59351847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09D653E7-21AD-4D36-8399-16DF002BE297</gtr:id><gtr:title>The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c81e36f4ff995ae0509b3fc01eba363"><gtr:id>0c81e36f4ff995ae0509b3fc01eba363</gtr:id><gtr:otherNames>Mannion NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56d890332798b2.66075204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAC9C4F6-2885-411C-86B4-5F698EF41311</gtr:id><gtr:title>Genetic heterogeneity in Cornelia de Lange syndrome (CdLS) and CdLS-like phenotypes with observed and predicted levels of mosaicism.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3982d000592c7bb3d227998a20f0c93b"><gtr:id>3982d000592c7bb3d227998a20f0c93b</gtr:id><gtr:otherNames>Ansari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>542f020ae06dd8.30661439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7515079-EF9D-4DE7-8EAC-4C80CC1F9006</gtr:id><gtr:title>Genome-wide mapping of embedded ribonucleotides and other noncanonical nucleotides using emRiboSeq and EndoSeq.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/494ba6196af3cd99ac66b5a0659118db"><gtr:id>494ba6196af3cd99ac66b5a0659118db</gtr:id><gtr:otherNames>Ding J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>56952437a033e4.85445114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1508122A-3E66-4DF9-81F4-12654C5B66B0</gtr:id><gtr:title>Quantification of epigenetic biomarkers: an evaluation of established and emerging methods for DNA methylation analysis.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1df0b11212d79c8eac6549a50054171"><gtr:id>d1df0b11212d79c8eac6549a50054171</gtr:id><gtr:otherNames>Redshaw N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>569524d846bb58.63467150</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F860B6CD-3650-4082-B085-E67EE7615ADC</gtr:id><gtr:title>Loss of ALDH18A1 function is associated with a cellular lipid droplet phenotype suggesting a link between autosomal recessive cutis laxa type 3A and Warburg Micro syndrome.</gtr:title><gtr:parentPublicationTitle>Molecular genetics &amp; genomic medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f06be73dbf095332a448a6508298737"><gtr:id>8f06be73dbf095332a448a6508298737</gtr:id><gtr:otherNames>Handley MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2324-9269</gtr:issn><gtr:outcomeId>542f0209d3eb52.30815280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE43521B-81A8-4B65-A8AC-98D8C7C11EC7</gtr:id><gtr:title>The frequent evolutionary birth and death of functional promoters in mouse and human.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db08ff5abd24875e320d0a8bc8033a29"><gtr:id>db08ff5abd24875e320d0a8bc8033a29</gtr:id><gtr:otherNames>Young RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>5695243715fd80.16156237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C96DAFC5-874F-4C90-8ED1-C351B639BA3B</gtr:id><gtr:title>Aberrant ribonucleotide incorporation and multiple deletions in mitochondrial DNA of the murine MPV17 disease model.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66569eacedd357dfa6b7a9c376f17e82"><gtr:id>66569eacedd357dfa6b7a9c376f17e82</gtr:id><gtr:otherNames>Moss CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5a391aeea94197.89671131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC9765A8-7173-4622-8D92-BAEBE366B94A</gtr:id><gtr:title>Exome sequencing to detect rare variants associated with general cognitive ability: a pilot study.</gtr:title><gtr:parentPublicationTitle>Twin research and human genetics : the official journal of the International Society for Twin Studies</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a9182b2ee4ce0895db9db0842c40332"><gtr:id>8a9182b2ee4ce0895db9db0842c40332</gtr:id><gtr:otherNames>Luciano M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1832-4274</gtr:issn><gtr:outcomeId>5695243774d4a7.48538180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8D8CD33-339A-41C9-8826-35395CA344E3</gtr:id><gtr:title>Bidirectional transcription initiation marks accessible chromatin and is not specific to enhancers.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db08ff5abd24875e320d0a8bc8033a29"><gtr:id>db08ff5abd24875e320d0a8bc8033a29</gtr:id><gtr:otherNames>Young RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>5a537fd681b880.87050900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>806CE866-77D3-4AC4-B52F-F3B8E4B9EAC9</gtr:id><gtr:title>Quantifying single nucleotide variant detection sensitivity in exome sequencing.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44f92eba4426d23d345c5ab693548a77"><gtr:id>44f92eba4426d23d345c5ab693548a77</gtr:id><gtr:otherNames>Meynert AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>pm_12555_25_23773188</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CD6ED30-FBB7-4325-9DCD-B97E2472FF37</gtr:id><gtr:title>Lineage-specific genomics: Frequent birth and death in the human genome: The human genome contains many lineage-specific elements created by both sequence and functional turnover.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db08ff5abd24875e320d0a8bc8033a29"><gtr:id>db08ff5abd24875e320d0a8bc8033a29</gtr:id><gtr:otherNames>Young RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>58be8ca8651103.28836099</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6566A858-6C05-4A6B-8B90-F9B8647D5316</gtr:id><gtr:title>Variant detection sensitivity and biases in whole genome and exome sequencing.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44f92eba4426d23d345c5ab693548a77"><gtr:id>44f92eba4426d23d345c5ab693548a77</gtr:id><gtr:otherNames>Meynert AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>542f0209a1b6c3.21758525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81C34979-2407-4CB3-9B62-98C8FC1A6A57</gtr:id><gtr:title>SuRFing the genomics wave: an R package for prioritising SNPs by functionality.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ead954606bce570e3dd4805236d71c38"><gtr:id>ead954606bce570e3dd4805236d71c38</gtr:id><gtr:otherNames>Ryan NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn><gtr:outcomeId>54481166e59507.48634315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BDACB65-038F-4E26-A7F0-EFB25C6E4F8D</gtr:id><gtr:title>A promoter-level mammalian expression atlas.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/323e91786338ef638749450b9312e13a"><gtr:id>323e91786338ef638749450b9312e13a</gtr:id><gtr:otherNames>FANTOM Consortium and the RIKEN PMI and CLST (DGT)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>542f030a4e06d8.34348895</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_U127597124</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>